RESEARCH PAPER / 2026-03-21
Rejuvenation of mesenchymal stromal cells via partial reprogramming enables scalable generation of transcriptionally diverse MSC libraries.
Abstract
Mesenchymal stromal cells (MSCs) are widely used in regenerative medicine, but their clinical utility is limited by replicative senescence. Strategies that reverse aging while maintaining MSC identity are urgently needed.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that partial reprogramming can rejuvenate mesenchymal stromal cells while preserving their identity. This research is relevant as it addresses the root cause of aging in MSCs, aiming to enhance their clinical utility in regenerative medicine.
Author of this paper? Send a correction.